ALPHA TRIBE

Vista Pharmaceuticals LtdBoard Meeting, 13-11-2025: Board Meeting

13-11-2025 | 03:56 pm

Vista Pharma's board approved Q2/H1 results: Q2 revenue Rs 1.65 Cr, net loss Rs 2.59 Cr. H1 revenue Rs 2.50 Cr, net loss Rs 3.88 Cr. Firm took Rs 2.05 Cr credit loss hit & issued warrants for 1.02 Cr shares, collecting Rs 3.08 Cr.

No comments yet. Be the first to comment!

All announcements from Vista Pharmaceuticals Ltd